#1400 on the rich list of 14,644 insiders
Mark Chin
Director at Enliven Therapeutics; Insider at Pyxis Oncology. Based in Boston, Massachusetts.
$112M
in disclosed stock, +$3.9M (+3.59%) today
Live prices, last trade 2:48 PM ET
- Rank
- 1400th of 14,644
- Companies held
- 2
- Largest holding
- ELVN, 97.4% of total
- Latest SEC filing
- Jun 2, 2022
What the $112M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Enliven Therapeutics ELVN Common Stock | Through entities affiliated with Arix Bioscience plc | 2,344,072 | $46.39 | $109M | 97.4% | Form 4, Jun 2, 2022 |
| Pyxis Oncology PYXS Common Stock | Indirectly (see filing footnote) | 1,745,761 | $1.61 | $2.8M | 2.5% | Form 4, Mar 31, 2022 |
| Pyxis Oncology PYXS Common Stock | Directly | 66,831 | $1.61 | $107K | 0.1% | Form 4, Mar 31, 2022 |
Share counts are the amounts Mark Chin reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1397 | James R. Brickman Chief Executive Officer, Green Brick Partners. Plano, TX | $112M |
| 1398 | Peter Juhas Chief Financial Officer, AerCap Holdings | $112M |
| 1399 | Daniel Harris Meyer Director, Shake Shack. New York, NY | $112M |
| 1400 | Mark Chin Director, Enliven Therapeutics. Boston, MA | $112M |
| 1401 | Matthew J. Murphy Chairman of the Board and CEO, Marvell Technology. Santa Clara, CA | $112M |
| 1402 | Kiran Kumar Choudary Chief Financial Officer, Rubrik. Palo Alto, CA | $111M |
| 1403 | Aaron J. Nahmad President, Watsco. Miami, FL | $111M |
Other Enliven Therapeutics insiders
All ELVN insiders- Joseph P. Lyssikatos$81.3MCHIEF SCIENTIFIC OFFICER. #1776 overall
- Samuel Kintz$41.3MPRESIDENT AND CEO. #2942 overall
- Anish Patel$10.9MCHIEF OPERATING OFFICER. #8255 overall
- Braden M Leonard$10.7M10% owner. #7748 overall
- David M. Mott$10.6MDirector. #4938 overall
- Richard A. Heyman$6.8MDirector. #9813 overall
Questions
How much stock does Mark Chin own?
Mark Chin holds $111,650,710 in listed stock based on SEC filings and current prices, mostly Enliven Therapeutics (ELVN). That ranks 1400th on the Stock Rich List.
Is this Mark Chin's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.